India's apex drug regulator has ordered an immediate stop to the production of 'Sure Rab' vaccines by Bio Med after multiple batches failed critical quality tests. The move comes amid growing concerns over vaccine safety in a country with the world's highest rabies death toll.
- CDSCO prohibited Bio Med from manufacturing anti-rabies vaccines for human use.
- Multiple batches of 'Sure Rab' failed the Bacterial Endotoxin Test (BET).
- Bio Med was previously blacklisted in 2018 due to a polio vaccine contamination scandal.
- India records the highest global rabies deaths, with over 5,700 fatalities annually.
The Central Drugs Standard Control Organisation (CDSCO), India's premier drug regulatory body, has taken stringent action against the Ghaziabad-based biopharmaceutical company Bio Med. The company has been issued a formal stop-production order for its anti-rabies vaccine, marketed as Sure Rab, after several batches were found to be 'Not of Standard Quality' (NSQ).
According to reports, at least three batches of the vaccine failed the Bacterial Endotoxin Test (BET). This is a critical safety procedure designed to detect lipopolysaccharides—toxins produced by certain bacteria that can cause severe fever and systemic inflammation when injected into the human body. Furthermore, some batches showed irregularities in bovine serum albumin levels, a protein used to stabilize the vaccine but which must remain within strict limits to ensure safety.
The crackdown followed a rigorous joint inspection conducted by the CDSCO and the Uttar Pradesh Food and Drug Administration (FDA) at the company's manufacturing facility. Bio Med is one of only five licensed manufacturers of anti-rabies vaccines in India, alongside giants like the Serum Institute of India and Bharat Biotech.
Why This Matters
BozokMedia analysis shows that this regulatory failure is particularly alarming given India's epidemiological profile. With approximately 58 lakh animal bites reported annually—including 47 lakh dog bites—the reliance on a few manufacturers makes the quality of every single vial a matter of national security. Any compromise in vaccine potency or purity can lead to preventable deaths in a population where rabies is almost always fatal once symptoms appear.
"Substandard drugs should never be taken lightly, but the consequences of a substandard vaccine can be far more serious from a public health perspective."
Historical Background: A Pattern of Failure
This is not the first time Bio Med has found itself in the regulatory crosshairs. In 2018, the company was blacklisted from supplying polio vaccines. This followed a major scandal involving the contamination of oral polio vaccines (OPV) with type-2 poliovirus, which contradicted World Health Organization (WHO) guidelines and posed a risk of vaccine-derived poliovirus cases.
| Parameter | Requirement | Bio Med 'Sure Rab' Result |
|---|---|---|
| Bacterial Endotoxin Test (BET) | Strictly within limits | FAILED (NSQ) |
| Bovine Serum Albumin | Trace amounts only | FAILED (Certain Batches) |
| Regulatory Status | Approved/Certified | Production Halted |
Frequently Asked Questions
Q1: What is the Bacterial Endotoxin Test (BET)?
It is a quality control test used to ensure that injectable drugs are free from pyrogens (fever-inducing substances) that could cause a dangerous immune response in patients.
Q2: Are there other alternatives to Sure Rab in India?
Yes, India has other major manufacturers including Indian Immunologicals Limited (IIL), Bharat Biotech, and the Serum Institute of India.
